309.56
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$318.84
Offen:
$314.85
24-Stunden-Volumen:
6.11M
Relative Volume:
0.85
Marktkapitalisierung:
$387.39B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
58.43
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
-10.48%
1M Leistung:
+3.80%
6M Leistung:
+17.41%
1J Leistung:
+135.64%
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LRCX
Lam Research Corp
|
309.56 | 387.39B | 21.68B | 6.71B | 6.00B | 5.298 |
|
ASML
Asml Holding Nv
|
1,750.24 | 672.27B | 41.20B | 12.41B | 11.15B | 32.12 |
|
AMAT
Applied Materials Inc
|
497.53 | 394.84B | 29.02B | 8.51B | 5.34B | 10.64 |
|
KLAC
Kla Corp
|
190.12 | 248.11B | 13.09B | 4.67B | 4.01B | 3.5373 |
|
TER
Teradyne Inc
|
383.85 | 60.01B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-05-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2026-05-05 | Eingeleitet | Seaport Research Partners | Buy |
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Lam Research Corp. stock underperforms Monday when compared to competitors - MarketWatch
Lam Research (LRCX) Set for Strong Q3 Results Amid Rising AI-Dri - GuruFocus
Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh Actuals & Estimates (SET:LRCX80) - TradingView
If You Invested $1000 In Lam Research Stock 10 Years Ago, You Would Have This Much Today - Benzinga
Lam Research Earnings Preview: What to Expect - Yahoo Finance
4,622 Lam Research Corporation $LRCX Shares Purchased by Wedmont Private Capital - MarketBeat
If You Invested $1000 in Lam Research a Decade Ago, This is How Much It'd Be Worth Now - Zacks Investment Research
Lam Research Corporation $LRCX Shares Bought by GAMMA Investing LLC - MarketBeat
LRCX4983304 Bond Profile: Coupon and Redemption - TradingView
Lam Research (LRCX) Suffers a Larger Drop Than the General Market: Key Insights - Zacks Investment Research
Lam Research (LRCX) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Lam Research Corp. stock outperforms competitors despite losses on the day - MarketWatch
Lam Research Corp. stock outperforms competitors despite losses on the day - MarketWatch
Lam Research Corp Stock (LRCX) Moved Down by 3.63% on Oct 8: What Signal Does It Send? - TradingKey
Advanced Energy Soars 40% YTD: Is the Stock Worth Buying Now? - TradingView
5 Ways to Invest Around Terafab Without Betting on Tesla or SpaceX - Zacks Investment Research
Can Applied Materials Sustain Momentum in Its AGS Business? - Zacks Investment Research
Lam Research Corporation (LRCX) Is a Trending Stock: Facts to Know Before Betting on It - Zacks Investment Research
Lam Research Corporation (LRCX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo! Finance Canada
Lam Research Corporation (LRCX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
MFS Research Series's Lam Research Corp(LRCX) Holding History - GuruFocus
Venture Visionary Partners LLC Grows Stake in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
AXTI Stock Rises 21% in a Month: Should You Buy, Sell or Hold? - Zacks Investment Research
Should You Invest in Lam Research Stock Despite Its Premium Valuation? - Zacks Investment Research
Should You Invest in Lam Research Stock Despite Its Premium Valuation? - Yahoo! Finance Canada
Should You Invest in Lam Research Stock Despite Its Premium Valuation? - Yahoo Finance
Lam Research Corporation (LRCX) options chain - Yahoo Finance UK
Lam Research Corporation (LRCX) options chain - Yahoo Finance UK
Zacks Industry Outlook Applied Materials, Lam Research and FormFactor - Zacks Investment Research
A Look at Lam Research Corp (LRCX) After 3.4% Decline -- GF Value $157.41 vs Price $333.93 - GuruFocus
Lam Research Corp Stock (LRCX) Moved Down by 3.87% on Oct 6: Drivers Behind the Movement - TradingKey
Should You Buy, Sell or Hold AMAT Stock at a P/S Valuation of 9.59X? - Zacks Investment Research
3 Stocks to Buy From the Prospering Semiconductor Industry - Zacks Investment Research
The Zacks Analyst Blog Highlights Lam, Taiwan, Marathon, NVIDIA, Micron and Alphabet - Zacks Investment Research
3 Stocks From AI & Energy to Buy Before Q3 Earnings Kick Off - Zacks Investment Research
Lam Research Corporation $LRCX Shares Sold by Neville Rodie & Shaw Inc. - MarketBeat
AI Drives Storage Demand: Will It Boost Lam Research's NAND Growth? - Zacks Investment Research
AI Drives Storage Demand: Will It Boost Lam Research's NAND Growth? - Yahoo! Finance Canada
What is Lam Research’s (LRCX) Economic Moat, and is it Widening or Narrowing? - Yahoo Finance
Lam Research Corporation (NASDAQ:LRCX) Stock Has Average Target Price of $364.01 According to Brokerages - MarketBeat
Analog Devices, AMD, KLA Corporation, Lam Research, and Marvell Technology Stocks Trade Up, What You Need To Know - Yahoo Finance
Lam Research (LRCX) Outpaces Stock Market Gains: What You Should Know - Zacks Investment Research
Lam Research (LRCX) Outpaces Stock Market Gains: What You Should Know - Yahoo! Finance Canada
Lam Research (LRCX) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Lam Research Corp. stock underperforms Friday when compared to competitors despite daily gains - marketwatch.com
LAM RESEARCH CORP (LRCX.NE) Balance Sheet - Yahoo! Finance Canada
Lam Research: This Rally Has Legs (Earnings Preview) (NASDAQ:LRCX) - Seeking Alpha
Lam Research Corp Stock (LRCX) Moved Up by 3.08% on Oct 2: What Signal Does It Send? - TradingKey
Are Computer and Technology Stocks Lagging Lam Research (LRCX) This Year? - Yahoo Finance
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lam Research Corp-Aktie (LRCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ARCHER TIMOTHY | President and CEO |
Sep 09 '26 |
Sale |
319.26 |
30,000 |
9,577,800 |
1,075,966 |
| ARCHER TIMOTHY | Officer |
Sep 09 '26 |
Proposed Sale |
319.26 |
30,000 |
9,577,800 |
0 |
| BETHANY MAYER | Director |
Sep 09 '26 |
Proposed Sale |
314.74 |
9,557 |
3,007,970 |
0 |
| Mayer Bethany | Director |
Sep 09 '26 |
Sale |
314.74 |
9,557 |
3,007,970 |
20,995 |
| Varadarajan Seshasayee | Officer |
Sep 02 '26 |
Proposed Sale |
291.32 |
59,750 |
17,406,370 |
0 |
| Varadarajan Seshasayee | Senior Vice President |
Sep 02 '26 |
Option Exercise |
39.25 |
39,750 |
1,560,047 |
233,026 |
| Varadarajan Seshasayee | Senior Vice President |
Sep 02 '26 |
Sale |
291.32 |
59,750 |
17,406,370 |
205,546 |
| Harter Ava | Officer |
Aug 31 '26 |
Proposed Sale |
302.46 |
5,000 |
1,512,300 |
0 |
| Harter Ava | Chief Legal Officer |
Aug 31 '26 |
Sale |
302.46 |
5,000 |
1,512,300 |
42,462 |
| ARCHER TIMOTHY | President and CEO |
Aug 06 '26 |
Sale |
300.00 |
30,000 |
9,000,000 |
1,075,966 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):